Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $381.87, demonstrating a +1.39% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.5%. At ...

Our lab data proves you can find top-performing cordless vacuums with long-lasting batteries and strong suction without ...

For CTOs and senior technology leaders, cloud cost optimization is no longer a back-office exercise—it’s a boardroom priority ...

The DP World Tour season is just heating up with multiple PGA Tour golfers now available to compete in some of its biggest tournaments. Traveling to the K Club for this week's Irish Open and Wentworth ...

Clemens Fischer has never smoked pot in his life, but he believes his new experimental drug could reap billions in sales—and ...

Rory McIlroy looks to help Team Europe to Ryder Cup victory at Bethpage Black from September 26-28, live on Sky Sports; McIlroy won the Amgen Irish Open in a play-off to claim fourth worldwide victory ...

TOLEDO, Ohio (WTVG) - Dravet Syndrome is a rare and severe form of epilepsy. Treatment options are limited and a local family is working to help change that. The family is hosting an event later this ...